🔎 Trials Near Me

Domov › Sladkorna bolezen tipa 2 › Texas › San Antonio

Klinične študije za Sladkorna bolezen tipa 2 v San Antonio, TX

37 študij za Sladkorna bolezen tipa 2 išče udeležence na lokacijah v San Antonio in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Vključevanje udeležencevFaza 3
  • NE Clin Res of San Antonio, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Vključevanje udeležencevFaza 3
  • IMA Clinical Research San Antonio, San Antonio
  • Pinnacle Clinical Research, LLC, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
  • in še 3
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Vključevanje udeležencevFaza 3
  • Pinnacle Clinical Research - San Antonio, San Antonio
  • Pinnacle Clinical Research, LLC, San Antonio
  • Consano Clinical Research, Shavano Park · 12 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07754461

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Vključevanje udeležencevFaza 1
  • Endeavor Clinical Trials, San Antonio
Starost 18–65 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07399678

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Vključevanje udeležencevFaza 3
  • VIP Trials, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • IMA Clinical Research San Antonio, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Research Site, San Antonio
  • Research Site, San Antonio
  • Research Site, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07784270

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • The University of Texas Health Science Center at San Antonio, San Antonio
Starost 18–65 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT02969798

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • AURORA-2 Clinical Site, San Antonio
  • AURORA-2 Clinical Site, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 2
  • AES - DRS - Synexus Clinical Research US, Inc. - San Antonio, San Antonio
  • Flourish Research - San Antonio - PPDS, San Antonio
Starost 18–75 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Pinnacle Clinical Research - San Antonio, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Vključevanje udeležencevFaza 2
  • Consano Clinical Research, LLC, Shavano Park · 12 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06897475

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • Consano Clinical Research, LLC, Shavano Park · 12 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Vključevanje udeležencevFaza 2
  • Clinical Advancement Center, San Antonio
  • University of Texas Health - San Antonio, San Antonio
Starost 18–80 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07271186

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • Quality Research Inc, San Antonio
  • Tekton Research Inc, San Antonio
  • Consano Clin Res-Shavano Park, Shavano Park · 12 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07668388

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 3
  • Research Site, San Antonio
  • Research Site, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Vključevanje udeležencevFaza 2
  • Diabetes & Glandular Disease Clinic, P.A., San Antonio
  • Texas Valley Clinical Research - San Antonio TX, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07296484

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Consano Clinical Research, LLC, Shavano Park · 12 mi stran
Starost 10–18 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07282613

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • Consano Clinical Research, LLC, Shavano Park · 12 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07215559

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Vključevanje udeležencevFaza 3
  • Research Site, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07662135

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Vključevanje udeležencevFaza 3
  • Clinical Advancement Center, San Antonio
  • The IMA Group IMA Clinical Trials of America Inc. CTA, San Antonio
  • Univ Of Texas Hlth Science Cntr, San Antonio
  • in še 2
Starost 45 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 3
  • Research Site, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07662109

Quantifying Hepatic Mitochondrial Fluxes in Humans

Vključevanje udeležencevFaza 4
  • Texas Diabetes Institute - University Health System, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
Starost 18–80 · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05305287

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

Vključevanje udeležencevFaza 3
  • Research Site, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT07664553

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

Vključevanje udeležencev
  • Tekton Research, San Antonio
Starost 18–75 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT07521475

SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 Diabetes

Vključevanje udeležencev
  • Brooke Army Medical Center, San Antonio
Starost 18–70 · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT07674628

SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia

Vključevanje udeležencevFaza 1
  • Texas Diabetes Institute/UH, San Antonio
Starost 30–75 · Vsi spoli · Posodobljeno 17. jul. 2026 · NCT07053306

SGLTi, Hepatic Glucose Production and Ketogenesis

Vključevanje udeležencevFaza 1
  • Texas Diabetes Institute/UH, San Antonio
Starost 30–75 · Vsi spoli · Posodobljeno 17. jul. 2026 · NCT05960656

SGLT2i, Hepatic Glucose Production, and SNS

Vključevanje udeležencevZgodnja faza 1
  • Texas Diabetes Institute/UH, San Antonio
Starost 30–75 · Vsi spoli · Posodobljeno 17. jul. 2026 · NCT07053293

SGLT2i, Pioglitazone, and Ketone Production in T2D

Vključevanje udeležencevFaza 1
  • Texas Diabetes Institute/UH, San Antonio
Starost 30–75 · Vsi spoli · Posodobljeno 17. jul. 2026 · NCT07053319

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Vključevanje udeležencevFaza 2
  • Diabetes & Glandular Disease Clinic, P.A., San Antonio
Starost 18–70 · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT07502508

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • Tekton Research, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 23. apr. 2026 · NCT07546929

ROME GS System Study

Vključevanje udeležencev
  • Flourish Research - San Antonio, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 21. apr. 2026 · NCT07518004

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

Vključevanje udeležencevFaza 4
  • University Health - Texas Diabetic Institute, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
Starost 18–70 · Vsi spoli · Posodobljeno 13. apr. 2026 · NCT06706284

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

Vključevanje udeležencevFaza 3
  • University Health System Texas Diabetic Institute, San Antonio
  • UT Health Science Center, San Antonio
Starost 18–75 · Vsi spoli · Posodobljeno 10. mar. 2026 · NCT06246799

Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

Vključevanje udeležencevZgodnja faza 1
  • University of Texas Health Science Center at San Antonio, San Antonio
Starost 18–80 · Vsi spoli · Posodobljeno 21. jan. 2026 · NCT06108076

Študije za Sladkorna bolezen tipa 2 v drugih mestih

Druge študije v San Antonio

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.